Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
24.50
+0.08 (0.33%)
At close: Sep 4, 2026, 4:00 PM EDT
24.20
-0.30 (-1.22%)
After-hours: Sep 4, 2026, 7:55 PM EDT
Elanco Animal Health Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Elanco Animal Health stock has a consensus rating of "Strong Buy" and an average price target of $31.21. The average 1-year stock price forecast is 27.39% higher than the current stock price, while the lowest is $26 (+6.12%) and the highest is $34 (+38.78%).
Price Target: $31.21 (+27.39%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Elanco Animal Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 11 | 11 | 11 | 11 |
| Buy | 4 | 4 | 5 | 5 | 5 | 4 |
| Hold | 2 | 2 | 1 | 1 | 1 | 2 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Reiterates $32 | Buy | Reiterates | $32 | +30.61% | Aug 24, 2026 |
| Barclays | Barclays | Buy Maintains $30 | Buy | Maintains | $30 | +22.45% | Aug 21, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $32 → $34 | Buy | Maintains | $32 → $34 | +38.78% | Aug 13, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
Financial Forecast
Revenue This Year
5.12B
from 4.72B
Increased by 8.68%
Revenue Next Year
5.40B
from 5.12B
Increased by 5.32%
EPS This Year
1.13
from 0.94
Increased by 20.48%
EPS Next Year
1.28
from 1.13
Increased by 13.00%
EPS and Forward PE are based on non-GAAP adjusted numbers.